Lineage
Lineage is a California-based biotechnology company that develops and commercializes novel cell therapies for the treatment of degenerative diseases.
Business Model:
Revenue: $14M
Employees: 51-200
Industries / Tags:
Detailed Lineage Information
Geographic Data
Address: 2173 Salk Avenue
City: Carlsbad
State: CA
Zip: 92008
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$36M
Raised Total:$67M
Social
Metrics
1,907,470Website Global Rank
11,361Website Monthly Traffic
Twitter Followers
Description
Lineage is a California-based biotechnology company that develops and commercializes novel cell therapies for the treatment of degenerative diseases.
Contact Phone:
+14422878963
Contact Email:
Lineage went public on 9/10/2015 on the NYSE
Listed Exchange:
NYSE
IPO Date:
9/10/2015
Ticker Symbol:
LCTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2017 | AgeX Therapeutics | Venture Round | 0 |
| 8/2017 | AgeX Therapeutics | Venture Round | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2017 | Grant | 1 | $2M |
Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority |
10/2014 | Post-IPO Equity | $31M | 5/2019 | Grant | $2.5M |
Israel Innovation Authority |
8/2020 | Convertible Note | $24.6M |
Juvenescence Ltd. |
8/2019 | Grant | $670.6k |
Small Business Innovation Research |
4/2009 | Post-IPO Equity | $3.4M | 9/2020 | Grant | $573k |
Israel Innovation Authority |
7/2020 | Grant | $13.5M |
Israel Innovation Authority |
5/2019 | Grant | 1 | $2.5M |
Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority |
5/2014 | Post-IPO Equity | $6.4M | 5/2010 | Post-IPO Equity | $8M | 5/2015 | Post-IPO Equity | $3.3M | 3/2014 | Post-IPO Equity | $3.5M | 6/2016 | Grant | 1 | $2.2M |
Israel Innovation Authority Israel Innovation Authority |
9/2016 | Post-IPO Equity | $10.5M | 3/2021 | Post-IPO Equity | $35.9M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2018 | Asterias Biotherapeutics | |
| 4/2012 | XenneX | |
| 2/2011 | Glycosan | |
| 1/2011 | Cell Targeting | |
| 4/2010 | ES Cell International Pte Ltd. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
